<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Toxic Dolls | Erickson Levine | Activity</title>
	<link>https://toxicdolls.com/members/whipsauce4/activity/</link>
	<atom:link href="https://toxicdolls.com/members/whipsauce4/activity/feed/" rel="self" type="application/rss+xml" />
	<description>Activity feed for Erickson Levine.</description>
	<lastBuildDate>Mon, 04 May 2026 16:22:51 +0000</lastBuildDate>
	<generator>https://buddypress.org/?v=</generator>
	<language>en-US</language>
	<ttl>30</ttl>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>2</sy:updateFrequency>
	
						<item>
				<guid isPermaLink="false">820e5832f5bd987eed8b703ad6ee5523</guid>
				<title>Erickson Levine posted an update: ) on the growth of CRC cells/xenografts in vitro and in vivo. [&#133;]</title>
				<link>https://toxicdolls.com/activity-2/p/8964/</link>
				<pubDate>Mon, 23 Jun 2025 18:40:12 +0000</pubDate>

									<content:encoded><![CDATA[<p>) on the growth of CRC cells/xenografts in vitro and in vivo. Moreover, PRMT5 and EZH2 were found to be significantly elevated and associated with poor prognosis in CRC patients. Conclusion PRMT5 functionally associates with EZH2 to promote CRC progression through epigenetically repressing CDKN2B expression. Thus, our findings raise the&hellip;<span class="activity-read-more" id="activity-read-more-8964"><a href="https://toxicdolls.com/activity-2/p/8964/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">9e8a01b3279c263cb8cd5cb4faa8499a</guid>
				<title>Erickson Levine became a registered member</title>
				<link>https://toxicdolls.com/activity-2/p/8882/</link>
				<pubDate>Mon, 23 Jun 2025 18:05:58 +0000</pubDate>

				
									<slash:comments>0</slash:comments>
				
							</item>
		
	</channel>
</rss>